A preliminary report of mitotane therapy of advanced renal and prostate cancer
Hogan, T.F.; Citrin, D.L.; Freeberg, B.L.
Cancer Treatment Reports 65(5-6): 539-540
1981
ISSN/ISBN: 0361-5960 PMID: 7237479 Document Number: 176905
Document emailed within 1 workday
Related Documents
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62Pavone-Macaluso, M.; Serretta, V.; Pavone, C.; Romano, C.; Daricello, G. 1989: Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate Archivos Espanoles de Urologia 42(Suppl 2): 197-205
Nicol, D.L.; Heathcote, P.S.; Kateley, G.D.; Lloyd, S. 1993: Advanced prostate cancer. the role of high priced hormone therapy Medical Journal of Australia 159(1): 16-19
Rodríguez Duarte, C.; Mattout, J.; Moreira, O.; Jiménez, R. 2002: Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report Archivos espanoles de urologia 55(7): 785-791
Colović, V.; Basić, D.T.; Oprić, D.; Djokić, J.Hadzi. 2009: Multiple cutaneous metastases of advanced prostate cancer: case report and a review of the literature Acta Chirurgica Iugoslavica 56(1): 105-107
Kvols, L.K.; Eagan, R.T.; Myers, R.P. 1977: Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report Cancer Treatment Reports 61(2): 311-312
Del Zingaro, M.; Boni, A.; Paladini, A.; Rossi De Vermandois, J.A.; Ciarletti, S.; Felici, G.; Ursi, P.; Cirocchi, R.; Mearini, E. 2019: Fournier's gangrene secondary to locally advanced prostate cancer: case report and review of the Literature Il Giornale di Chirurgia 40(6): 481-496
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Møller, K.A.; Andersen, A.P. 1981: Peroral administration of medroxyprogesterone acetate (MPA) in advanced cancer of the breast. A preliminary report Acta obstetricia et gynecologica Scandinavica. Supplement 101: 47-48
Szatkowska, L.; Mazurkiewicz, M.; Brzozowska, A. 2001: Cisplatin and vinorelbine therapy of previously treated advanced breast cancer (preliminary studies) Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 148-149
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Lehnert, M.; Biffl, G.; Wascher, H.; Jordis-Lohausen, K.; Wählby, S. 1986: A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase Ii study Seminars in Oncology 13(1 Suppl 1: 32-34
Yen, M.L.; Chen, Y.C.; Lin, M.T.; Liu, M.C.; Tang, J.L.; Wang, C.H.; Hsieh, C.Y. 1992: High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: preliminary report of a new strategy Transplantation Proceedings 24(4): 1533-1535
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Karelin, M.I.; Atroshchenko, A.V.; Shkol'nik, M.I.; Leonenkov, R.V.; Belov, A.D.; Kharitonov, M.V. 2008: Combination therapy of localized and locally-advanced renal-cell cancer using preoperative arterial embolization Voprosy Onkologii 54(1): 95-97
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Kondo, S.; Katoh, H.; Omi, M.; Hirano, S.; Ambo, Y.; Tanaka, E.; Okushiba, S.; Morikawa, T.; Kanai, M.; Yano, T. 2001: Radical distal pancreatectomy with en bloc resection of the celiac artery, plexus, and ganglions for advanced cancer of the pancreatic body: a preliminary report on perfect pain relief JOP: Journal of the pancreas 2(3): 93-97
Litjens, T.T.; Fernandez del Moral, P.; van Laarhoven, J.P.; Weil, E.H.; Debruyne, F.M. 1986: Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results Nederlands Tijdschrift Voor Geneeskunde 130(17): 787-790
Ratanarat, R.; Chaipruckmalakarn, T.; Laowahutanont, N.; Larpparisuth, N.; Vasuvattakul, S. 2012: Efficacy and hemodynamic outcome of prolonged intermittent renal replacement therapy (PIRRT) in critically ill patients: a preliminary report Journal of the Medical Association of Thailand 95 Suppl. 2: S265-S271
Watanabe, S.; Mayama, M.; Oguro, M.; Wakatsuki, S.; Majima, H. 1990: A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(10): 2105-2108